Colorectal cancer most often spreads to the liver. When those liver tumors (called liver metastases) can be removed with ...
The investigational drug rinatabart sesutecan (Rina-S) shrank tumors in 45.9% of patients with platinum-resistant ovarian ...
In a video interview with CURE, Dr. Elizabeth K. Lee explained that how a treatment affects daily life matters as much as how well it works.
On Sept. 30, 2026, the FDA withdrew the accelerated approval of Zepzelca (lurbinectedin) for adults with metastatic small ...
The hardest part of living with metastatic triple-negative breast cancer, a cancer that has spread to other parts of the body ...
Dr. Neel Chudgar of Montefiore Einstein answers the most searched questions about lung cancer surgery, including risks, ...
Challenge yourself after cancer by building healthier habits, strengthening relationships, managing stress and embracing new experiences for a healthier life. When I was a young boy, I dreamt of being ...
The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...
Liver cancer treatment has changed a lot in five years, and how it changed tells you a lot about where it’s going. Most of ...
The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...
African American patients with newly diagnosed multiple myeloma were less likely than White patients to receive drugs that ...
American Society for Radiation Oncology (ASTRO) published its first clinical practice guideline on radiation therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results